NEW DELHI: The country's first Covid virus vaccine development process has accelerated, The trial of this vaccine on humans will be launched as soon as possible . The vaccine, jointly developed by the Indian Medical Research Council (ICMR), private pharmaceutical company Bharat Biotech India Ltd and National Institute of Virology (NIV), is being tested on more than 1,000 people in two phases.
The first phase of the vaccine will be on 375 patients and the second phase on 750 patients. Already, the Directorate of Drug Control (DGCI) has approved the first 2 phases of trial. The clinical trial will be held in 12 institutions, including Jeevanrekha Hospital, Belgaum, Karnataka.
Phase 3 Vaccines: According to the World Health Organization, there are a total of 19 vaccines being processed worldwide. Two of these vaccines, AstraZeneca and Sinovacare, have reached the third stage of human experimentation. Now China's Cinovac Biotech Company has achieved this and is now in the process of finalizing its vaccine. Six companies, including Pfizer, Novavax and Cadilla Healthcare, are currently testing Phase 2 of the vaccine.